This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types) including Monoclonal Antibodies, Tyrosine Kinase, Inhibitors, Cancer Vaccines, Cytokines, Gene Therapy, Traditional Chemotherapy.
The report has a special emphasis on novel treatments and provides an overview of treatments on the market and in development for each cancer type. Trend analysis, market share and company profiles of over 50 major players, smaller participants and new entrants is a part of the market analysis in this report.
Secondary and primary research was used to determine market size for cancer types by product sales in this report. Methodology included telephone interviews and email correspondence with company representatives, researchers, government representatives, and physicians. These interviews were conducted with the purpose of capturing the perspectives from industry participants on the market opportunity and current trends.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 20 5. Historical data was provided for the years 20 0 through 20 4, with forecast data provided for 20 6 through 2020. Compound annual growth rates (CAGRs) are provided for the 20 0-20 5, 20 5-2020 and 20 0-2020 periods for each segment covered. Competitive analysis is provided for the year 20 5. The forecasted market analysis for 20 5-2020 was based on probability of approval and sales of products in late stage development, competitive trends, product marketing, cancer epidemiology, and demographic trends.
Companies covered include Novartis, Pfizer, Abbvie, Bayer, Merck and many other companies.